Read the latest research articles and studies exploring the use of Deep TMS in various disorders.
BrainsWay is actively exploring expanded uses for Deep TMS across numerous psychiatric and neurological conditions.
Explore our active clinical trials below and reach out to the contacts listed to enroll.
Baycrest Health Sciences, Toronto, Canada Alzheimer’s disease is an increasing issue in the aging population with 66 million
Ben Gurion University of the Negev, Israel Stroke is among the principal causes of death worldwide and even in the best-case
Ambroise Paré hospital France, Henri Mondor hospital France, Oslo University Norwey Neuropathy is common in the diabetic population,
Learn more about how Deep TMS can provide relief to people suffering from Major Depressive Disorder and Obsessive-Compulsive Disorder.
TMS differs from ECT in a number of significant ways, offering a non-invasive, FDA-cleared treatment...
TMS therapy offers proven symptom alleviation. But who is it for and how should you prepare for its treatment...
The mental health ramifications of COVID-19 are still developing, with numerous studies finding depression...
View upcoming and on-demand educational webinars.
Overview of the preclinical and clinical work that led to FDA clearance of Deep TMS for Smoking Cessation
Dr. Mark George
Medical University of South Carolina
Tue, December 1
5:00 pm EST
Hear firsthand from patients how BrainsWay’s innovative treatments have helped them.
Take an in-depth look at how BrainsWay’s technology works.